It's important to not lose focus on the Positive Data delivering a Complete Response.
2025 is looking to deliver another bumpy ride for Biotech , had some great winners last year obviously CHM is not in that category but now with Rebecca at the helm and some cash in the Bank coupled to Positive data we should start to see the climb back to at least the suspension price of 1.4c..
The entire handling of the CR late last year really needs to be looked at by regulators but in the end it raised up the necessary funds to continue forward , plus Hopper and Co have stumped up another $5m and if there was no hope of success here , he and his fellow funders would have let CHM slide into oblivion..
Noted is the fact that many CHM holders also hold another Hopper Company that has also suffered significant SH Value loss whilst awaiting more Beautiful Data.....,, I just cant see CHM falling away to the side as the reputational damage would be hugely significant and damage the other Companies ability to raise funds in the future.. the old house of cards theory..
All the best of luck to Holders for 2025.. CHM is still inside my Top 5 Holdings ,, NZT
CHM Price at posting:
0.7¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)